Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Scutellaria Zhengqi capsule is a traditional Chinese medicine (TCM) formulation developed by Guangzhou University of Chinese Medicine for the treatment of infectious diarrhea. It is specifically indicated for patients presenting with the TCM pattern of 'dampness obstructing the spleen and stomach.' The capsule is a multi-ingredient herbal product, likely featuring *Scutellaria baicalensis* (Huangqin) as a primary component, which is traditionally used for its heat-clearing, dampness-drying, and anti-pathogenic properties. The drug has undergone Phase 3 clinical testing in China to evaluate its safety and efficacy in reducing symptoms of acute infectious diarrhea over a short-term (3-day) treatment period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Scutellaria Zhengqi capsule.